Market Place
Upload your Marketing & Sales content on your company Virtual Booth, click HERE
X
Please Wait
Applying Filters...
01 Flamma S.p.A. (1)
01 Rilzabrutinib (1)
01 Italy (1)
10
PharmaCompass offers a list of Rilzabrutinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rilzabrutinib manufacturer or Rilzabrutinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rilzabrutinib manufacturer or Rilzabrutinib supplier.
PharmaCompass also assists you with knowing the Rilzabrutinib API Price utilized in the formulation of products. Rilzabrutinib API Price is not always fixed or binding as the Rilzabrutinib Price is obtained through a variety of data sources. The Rilzabrutinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rilzabrutinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rilzabrutinib, including repackagers and relabelers. The FDA regulates Rilzabrutinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rilzabrutinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Rilzabrutinib supplier is an individual or a company that provides Rilzabrutinib active pharmaceutical ingredient (API) or Rilzabrutinib finished formulations upon request. The Rilzabrutinib suppliers may include Rilzabrutinib API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rilzabrutinib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rilzabrutinib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rilzabrutinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rilzabrutinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rilzabrutinib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rilzabrutinib suppliers with NDC on PharmaCompass.
We have 1 companies offering Rilzabrutinib
Get in contact with the supplier of your choice:
